Unaudited Financial results for the quarter ended 30.06.2025
Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
- Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Jul 15 2025
Later from Vista Pharmaceuticals
- Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
- Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals